Approaches to Identifying Anti-Viral Compounds/Therapies Focusing on COVID-19/SARs-CoV-2 or Related Virus
Submission deadline: May 1
Editor-in-Chief Bob Campbell, Ph.D. (Eli Lilly & Company) and Editorial Board Member Timothy P. Spicer, Ph.D. (Scripps Research) invite submissions centered around approaches to identifying anti-viral compounds/therapies focusing on COVID-19/SARs-CoV-2 or related viruses.
All Papers Will be Published Open Access
------------------------------
Christine Diedrich
Publishing Manager
SLAS
Oak Park IL
+1.630.256.7527 x106
------------------------------